Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PB) Free Cash Flow (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Free Cash Flow for 14 consecutive years, with $21.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 136.46% year-over-year to $21.6 million, compared with a TTM value of $3.1 million through Dec 2025, up 126.61%, and an annual FY2025 reading of $3.1 million, up 126.61% over the prior year.
  • Free Cash Flow was $21.6 million for Q4 2025 at Global Medical REIT, up from $17.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $181.8 million in Q4 2021 and bottomed at -$130.6 million in Q3 2022.
  • Average Free Cash Flow over 5 years is $2.6 million, with a median of $15.4 million recorded in 2023.
  • Peak annual rise in Free Cash Flow hit 190.65% in 2021, while the deepest fall reached 1457.49% in 2021.
  • Year by year, Free Cash Flow stood at $181.8 million in 2021, then tumbled by 90.11% to $18.0 million in 2022, then fell by 7.59% to $16.6 million in 2023, then tumbled by 456.42% to -$59.2 million in 2024, then surged by 136.46% to $21.6 million in 2025.
  • Business Quant data shows Free Cash Flow for GMRE-PB at $21.6 million in Q4 2025, $17.6 million in Q3 2025, and -$46.6 million in Q2 2025.